Good Care for You and Your Baby While Receiving Opioid Use Disorder Treatment

This series of four fact sheets emphasizes the importance of continuing a mother's treatment for opioid use disorder (OUD) throughout pregnancy. The series includes information on OUD and pregnancy, OUD treatment, neonatal abstinence syndrome, and considerations to address before hospital discharge.

This fact sheet (3 of 4) talks about what pregnant women with opioid use disorder should know about and expect after the birth of their baby. This resource includes information about neonatal abstinence syndrome, baby’s needs after birth, and do’s and don’ts for understanding and responding to baby’s needs.

This fact sheet (1 of 4) gives pregnant women with opioid use disorder (OUD) helpful steps to ensure they have a healthy pregnancy and a healthy baby. This resource includes things to know about OUD and pregnancy, and do's and don'ts to keep mother and baby healthy during pregnancy.

This fact sheet (2 of 4) addresses how treatment of pregnant women with opioid use disorder (OUD) can help women have a healthy pregnancy and a healthy baby. This resource describes managing OUD with a treatment plan that includes medicines and counseling.

This manual provides guidelines for the operation of opioid treatment programs. It covers patient assessment, treatment planning, and recovery care. The manual also offers guidance for medication-assisted treatment for methadone and buprenorphine, and overdose and relapse prevention.

The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.